Table 5 Summary of construct validity analysis results
Hypotheses tested | # of Hypotheses tested | # of Hypotheses confirmed (%) | |
|---|---|---|---|
Canada | Ireland | ||
Convergent construct validity | 15 | 13 (87 %) | 10 (67 %) |
WHODAS 2.0 scores will moderately(≥0.50) to strongly (≥0.70) correlatewith HDQ scores | |||
Convergent construct validity | 18 | 14 (78 %) | 12 (67 %) |
SF-36 scores will weakly (≥0.30) to strongly (≥0.70) correlate with HDQ scores | |||
Divergent construct validity | 7 | (71 %) | 0 (0 %) |
MOS-SS scores will weakly (≥0.30) to moderately (≥0.50) correlate with HDQ scores | |||
Total # of correlation hypotheses tested | 40 | 32 (80 %) | 22 (55 %) |
Known groups validity | 2 | 2 (100 %) | |
Older participants with morecomorbidity (Canadian sample) will have higher total HDQ presence and severity scores | |||